Table 1.
Clinical characteristics of 102 patients with TGCT
| Variables | Median (IQR) or number of cases (%) | |
|---|---|---|
| Age (years) | 34 (26 - 40) | |
| LDH (IU/ml) | 240 (170 - 463) | |
| αFP (ng/ml) | 5 (2 - 141) | |
| βhCG (mIU/ml) | 1.7 (0 – 20.2) | |
| Peripheral blood white blood cell count (/μl) | (n = 80) | 6800 (5900 - 8375) |
| Peripheral blood neutrophil count (/μl) | (n = 68) | 4300 (3542 - 5937) |
| T stage | T1 | 58 (56.9) |
| T2 | 29 (28.4) | |
| T3 | 13 (12.7) | |
| T4 | 2 (2.0) | |
| N stage | N0 | 72 (70.6) |
| N1 | 9 (8.8) | |
| N2 | 7 (6.9) | |
| N3 | 14 (13.7) | |
| M stage | M0 | 92 (90.2) |
| M1a | 9 (8.8) | |
| M1b | 1 (1.0) |
TGCT testicular germ cell tumor, IQR interquartile range, LDH lactate dehydrogenase, AFP α feto protein, βhCG β human chorionic gonadotropin